HIGHLIGHTS
- who: Chandra C. Ghosh from the (UNIVERSITY) have published the article: Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition, in the Journal: (JOURNAL) of 14/06/2022
- what: This study was designed to test the hypothesis that regional intravascular infusion of class C TLR9 agonists can reprogram the LM-MDSC compartment to create a more immuneresponsive TME. The authors demonstrate that regional infusion of a class C TLR9 agonist reduced MDSC abundance in LM and enhanced the antitumor efficacy of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.